Activist Investor 13D, 13G Filings


This page shows a list of all the recent 13D/G filings made by Smith Robert J. Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

DateForm Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2018‑08‑24 SC 13D/A SENS / Senseonics Holdings, Inc. 13,629,339 14,891,798 9.26
2018‑04‑25 SC 13D SENS / Senseonics Holdings, Inc. 7,964,810 13,629,339 71.12
2018‑04‑14 SC 13D/A TXMD / TherapeuticsMD, Inc. 12,959,108 9,938,708 -23.31
2018‑04‑13 SC 13D CVRS / Corindus Vascular Robotics, Inc. 11,215,209 14,302,124 27.52
2018‑02‑14 SC 13D/A TXMD / TherapeuticsMD, Inc. 12,157,505 12,959,108 6.59
2018‑02‑14 SC 13D/A CRVW / Careview Communications, Inc. 13,605,506 9,590,506 -29.51
2017‑03‑23 SC 13D/A CRVW / Careview Communications, Inc. 13,605,506
2017‑03‑22 SC 13D/A TXMD / TherapeuticsMD, Inc. 12,157,505
2017‑02‑24 SC 13G SENS / Senseonics Holdings, Inc. 7,964,810 8.51
2017‑02‑09 SC 13G CVRS / Corindus Vascular Robotics, Inc. 10,718,287 11,215,209 4.64 7.97 -0.38
2016‑02‑16 SC 13G CVRS / Corindus Vascular Robotics, Inc. 10,718,287 8.0